Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Ovarian Neoplasms |
Free Subscription
1 Am J Obstet Gynecol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
A modified diffusion-weighted MRI-based model from the radiologist's perspective:
improved performance in determining the surgical resectability for advanced
high-grade serous ovarian cancer.
Am J Obstet Gynecol. 2024 Mar 1:S0002-9378(24)00415.
PubMed
Abstract available
Contrast-enhanced CT radiomics for preoperative prediction of stage in epithelial
ovarian cancer: a multicenter study.
BMC Cancer. 2024;24:307.
PubMed
Abstract available
A clinicopathological study about the epidemiology of granulosa cell tumors in
Lebanon.
BMC Cancer. 2024;24:309.
PubMed
Abstract available
Assessing the risk to develop a growing teratoma syndrome based on molecular and
epigenetic subtyping as well as novel secreted biomarkers.
Cancer Lett. 2024;585:216673.
PubMed
Abstract available
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha
(FRalpha)-targeting antibody-drug conjugate, in combination with carboplatin and
bevacizumab in patients with platinum-sensitive ovarian cancer.
Gynecol Oncol. 2024;185:186-193.
PubMed
Abstract available
Real world challenges and disparities in the systemic treatment of ovarian
cancer.
Gynecol Oncol. 2024;185:180-185.
PubMed
Abstract available
Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma.
Int J Cancer. 2024 Jan 11. doi: 10.1002/ijc.34844.
PubMed
Abstract available
HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and
ToGA Immunohistochemical Scoring.
Int J Gynecol Pathol. 2024 Mar 4. doi: 10.1097/PGP.0000000000000972.
PubMed
Abstract available
Targeting and monitoring ovarian cancer invasion with an RNAi and peptide
delivery system.
Proc Natl Acad Sci U S A. 2024;121:e2307802121.
PubMed
Abstract available
Thank you for your interest in scientific medicine.